Cargando…
Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
The messenger RNA (mRNA) vaccines for COVID-19, Pfizer-BioNTech and Moderna, were authorized in the US on an emergency basis in December of 2020. The rapid distribution of these therapeutics around the country and the world led to millions of people being vaccinated in a short time span, an action t...
Autores principales: | Sfera, Adonis, Hazan, Sabine, Anton, Jonathan J., Sfera, Dan O., Andronescu, Christina V., Sasannia, Sarvin, Rahman, Leah, Kozlakidis, Zisis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503827/ https://www.ncbi.nlm.nih.gov/pubmed/36160443 http://dx.doi.org/10.3389/fphar.2022.995481 |
Ejemplares similares
-
Receptor-Independent Therapies for Forensic Detainees with Schizophrenia–Dementia Comorbidity
por: Sfera, Adonis, et al.
Publicado: (2023) -
Bromodomains in Human-Immunodeficiency Virus-Associated Neurocognitive Disorders: A Model of Ferroptosis-Induced Neurodegeneration
por: Sfera, Adonis, et al.
Publicado: (2022) -
Long COVID as a Tauopathy: Of “Brain Fog” and “Fusogen Storms”
por: Sfera, Adonis, et al.
Publicado: (2023) -
Recent Developments in Protein Lactylation in PTSD and CVD: Novel Strategies and Targets
por: Kozlakidis, Zisis, et al.
Publicado: (2023) -
Virus-Induced Membrane Fusion in Neurodegenerative Disorders
por: Osorio, Carolina, et al.
Publicado: (2022)